These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 36755360)

  • 21. Neutralization sensitivity, fusogenicity, and infectivity of Omicron subvariants.
    Wang XJ; Yao L; Zhang HY; Zhu KL; Zhao J; Zhan BD; Li YK; He XJ; Huang C; Wang ZY; Jiang MD; Yang P; Yang Y; Wang GL; Wang SQ; Dai EH; Gao HX; Ma MJ
    Genome Med; 2022 Dec; 14(1):146. PubMed ID: 36581867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Humoral and Cellular Immune Responses against SARS-CoV-2 after Third Dose BNT162b2 following Double-Dose Vaccination with BNT162b2 versus ChAdOx1 in Patients with Cancer.
    Debie Y; Van Audenaerde JRM; Vandamme T; Croes L; Teuwen LA; Verbruggen L; Vanhoutte G; Marcq E; Verheggen L; Le Blon D; Peeters B; Goossens ME; Pannus P; Ariën KK; Anguille S; Janssens A; Prenen H; Smits ELJ; Vulsteke C; Lion E; Peeters M; van Dam PA
    Clin Cancer Res; 2023 Feb; 29(3):635-646. PubMed ID: 36341493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High Neutralizing Antibody Levels Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.1 and BA.2 After UB-612 Vaccine Booster.
    Guirakhoo F; Wang S; Wang CY; Kuo HK; Peng WJ; Liu H; Wang L; Johnson M; Hunt A; Hu MM; Monath TP; Rumyantsev A; Goldblatt D
    J Infect Dis; 2022 Oct; 226(8):1401-1406. PubMed ID: 35723969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Homotypic and heterotypic immune responses to Omicron variant in immunocompromised patients in diverse clinical settings.
    Ferreira VH; Solera JT; Hu Q; Hall VG; Arbol BG; Rod Hardy W; Samson R; Marinelli T; Ierullo M; Virk AK; Kurtesi A; Mavandadnejad F; Majchrzak-Kita B; Kulasingam V; Gingras AC; Kumar D; Humar A
    Nat Commun; 2022 Aug; 13(1):4489. PubMed ID: 35927279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular and humoral functional responses after BNT162b2 mRNA vaccination differ longitudinally between naive and subjects recovered from COVID-19.
    Lozano-Rodríguez R; Valentín-Quiroga J; Avendaño-Ortiz J; Martín-Quirós A; Pascual-Iglesias A; Terrón-Arcos V; Montalbán-Hernández K; Casalvilla-Dueñas JC; Bergón-Gutiérrez M; Alcamí J; García-Pérez J; Cascajero A; García-Garrido MÁ; Balzo-Castillo ÁD; Peinado M; Gómez L; Llorente-Fernández I; Martín-Miguel G; Herrero-Benito C; Benito JM; Rallón N; Vela-Olmo C; López-Morejón L; Cubillos-Zapata C; Aguirre LA; Fresno CD; López-Collazo E
    Cell Rep; 2022 Jan; 38(2):110235. PubMed ID: 34986327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SARS-CoV-2 Antibody Responses to the Ancestral SARS-CoV-2 Strain and Omicron BA.1 and BA.4/BA.5 Variants in Nursing Home Residents After Receipt of Bivalent COVID-19 Vaccine - Ohio and Rhode Island, September-November 2022.
    Canaday DH; Oyebanji OA; White EM; Bosch J; Nugent C; Vishnepolskiy I; Abul Y; Didion EM; Paxitzis A; Sundheimer N; Ragavapuram V; Wilk D; Keresztesy D; Cao Y; St Denis K; McConeghy KW; McDonald LC; Jernigan JA; Mylonakis E; Wilson BM; King CL; Balazs AB; Gravenstein S
    MMWR Morb Mortal Wkly Rep; 2023 Jan; 72(4):100-106. PubMed ID: 36701254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cumulative incidence of SARS-CoV-2 infection in the general population of the Valencian Community (Spain) after the surge of the Omicron BA.1 variant.
    Camacho J; Giménez E; Albert E; Zulaica J; Álvarez-Rodríguez B; Torres I; Rusu L; Burgos JS; Peiró S; Vanaclocha H; Limón R; Alcaraz MJ; Sánchez-Payá J; Díez-Domingo J; Comas I; Gonzáles-Candelas F; Geller R; Navarro D;
    J Med Virol; 2023 Jan; 95(1):e28284. PubMed ID: 36333837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunological imprinting of humoral immunity to SARS-CoV-2 in children.
    Dowell AC; Lancaster T; Bruton R; Ireland G; Bentley C; Sylla P; Zuo J; Scott S; Jadir A; Begum J; Roberts T; Stephens C; Ditta S; Shepherdson R; Powell AA; Brent AJ; Brent B; Baawuah F; Okike I; Beckmann J; Ahmad S; Aiano F; Garstang J; Ramsay ME; Azad R; Waiblinger D; Willett B; Wright J; Ladhani SN; Moss P
    Nat Commun; 2023 Jun; 14(1):3845. PubMed ID: 37386081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inactivated vaccine fueled adaptive immune responses to Omicron in 2-year COVID-19 convalescents.
    Liu M; Zhang J; Li L; Tian J; Yang M; Shang B; Wang X; Li M; Li H; Yue C; Yao S; Lin Y; Guo Y; Zong K; Zhang D; Zhao Y; Cai K; Dong S; Xu S; Zhan J; Gao GF; Liu WJ
    J Med Virol; 2023 Aug; 95(8):e28998. PubMed ID: 37548149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Omicron variants breakthrough infection elicited higher specific memory immunity than third dose booster in healthy vaccinees.
    Yu P; Liu Z; Zhu Z; Yang J; Deng M; Chen M; Lai C; Kong W; Xiong S; Wan L; Mai W; Chen L; Lei Y; Khan SA; Ruan J; Kang A; Guo X; Zhou Q; Li W; Chen Z; Liang Y; Li P; Zhang L; Ji T
    Virol Sin; 2023 Apr; 38(2):233-243. PubMed ID: 36603767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A 1-year longitudinal study on COVID-19 convalescents reveals persistence of anti-SARS-CoV-2 humoral and cellular immunity.
    Li Y; Wang X; Shen XR; Geng R; Xie N; Han JF; Zhang QM; Shi ZL; Zhou P
    Emerg Microbes Infect; 2022 Dec; 11(1):902-913. PubMed ID: 35240947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS-CoV-2 Omicron BA.1 variant breakthrough infections in nursing home residents after an homologous third dose of the Comirnaty® COVID-19 vaccine: Looking for correlates of protection.
    Torres I; Giménez E; Albert E; Zulaica J; Álvarez-Rodríguez B; Burgos JS; Peiró S; Limón R; Vanaclocha H; Rodado C; Botija P; Sifre A; Tur B; Lozano RA; Orosa I; Vicente-Ruiz M; Carrión RJ; Clari MÁ; Sánchez-Payá J; Díez-Domingo J; Comas I; González-Candelas F; Geller R; Navarro D;
    J Med Virol; 2022 Sep; 94(9):4216-4223. PubMed ID: 35585782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Previous COVID-19 Vaccination on Humoral Immunity 3 Months after SARS-CoV-2 Omicron Infection and Booster Effect of a Fourth COVID-19 Vaccination 2 Months after SARS-CoV-2 Omicron Infection.
    Kim J; Seo H; Kim HW; Kim D; Kwon HJ; Kim YK
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36366556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross neutralization of SARS-CoV-2 omicron subvariants after repeated doses of COVID-19 mRNA vaccines.
    Luczkowiak J; Rivas G; Labiod N; Lasala F; Rolo M; Lora-Tamayo J; Mancheno-Losa M; Rial-Crestelo D; Pérez-Rivilla A; Folgueira MD; Delgado R
    J Med Virol; 2023 Jan; 95(1):e28268. PubMed ID: 36319593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous measurement of multiple variant-specific SARS-CoV-2 neutralizing antibodies with a multiplexed flow cytometric assay.
    Liu H; Varvel S; Chen G; McConnell J; Caffrey R; Galdzicka M; Shabahang S
    Front Immunol; 2022; 13():1039163. PubMed ID: 36505453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Humoral immune response to authentic circulating severe acute respiratory syndrome coronavirus 2 variants elicited by booster vaccination with distinct receptor-binding domain subunits in mice.
    Jiang Y; Zhang H; Yu J; Huang D; Zhai L; Li M; Wang Y; Ren Z; Zou L; Zheng Z; Hu H; Zhang J; Zhang B; Zhao W; Yang X; Li B; Shen C
    J Med Virol; 2022 Sep; 94(9):4533-4538. PubMed ID: 35614018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody Avidity and Neutralizing Response against SARS-CoV-2 Omicron Variant after Infection or Vaccination.
    Dapporto F; Marchi S; Leonardi M; Piu P; Lovreglio P; Decaro N; Buonvino N; Stufano A; Lorusso E; Bombardieri E; Ruello A; Viviani S; Molesti E; Trombetta CM; Manenti A; Montomoli E
    J Immunol Res; 2022; 2022():4813199. PubMed ID: 36093434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune Response to Third and Fourth COVID-19 Vaccination in Hemodialysis Patients and Kidney Transplant Recipients.
    Affeldt P; Koehler FC; Brensing KA; Gies M; Platen E; Adam V; Butt L; Grundmann F; Heger E; Hinrichs S; Kalisch N; Oehm S; Steger G; Wirtz M; Benzing T; Stippel D; Klein F; Kurschat C; Müller RU; Di Cristanziano V
    Viruses; 2022 Nov; 14(12):. PubMed ID: 36560648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Waning Neutralizing Antibody Responses Against the Omicron Variant 6 Months After Natural Severe Acute Respiratory Syndrome Coronavirus 2 Infection (With or Without Subsequent Coronavirus Disease 2019 [COVID-19] Vaccination) Versus 2-Dose COVID-19 Vaccination.
    Lim SY; Park S; Kim JY; Kim S; Jee Y; Kim SH
    Clin Infect Dis; 2022 Dec; 75(12):2243-2246. PubMed ID: 35686300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa.
    Vesin B; Lopez J; Noirat A; Authié P; Fert I; Le Chevalier F; Moncoq F; Nemirov K; Blanc C; Planchais C; Mouquet H; Guinet F; Hardy D; Vives FL; Gerke C; Anna F; Bourgine M; Majlessi L; Charneau P
    Mol Ther; 2022 Sep; 30(9):2984-2997. PubMed ID: 35484842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.